HECP-1000 Officially Receives Taiwan FDA

We are pleased to announce that our HECP-1000 device has successfully obtained approval from the Taiwan FDA this May, marking a significant milestone in the history of external counterpulsation (ECP) products.

 

The Taiwan FDA approval is a recognition of the safety and efficacy of the HECP-1000 and reflects our commitment to providing advanced solutions that enhance health and well-being.

 

We are excited to introduce the HECP-1000 to the public in Taiwan and look forward to continuing our innovation in the medical device field.